A.R. Bradwell

14.8k total citations · 1 hit paper
247 papers, 10.2k citations indexed

About

A.R. Bradwell is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, A.R. Bradwell has authored 247 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 61 papers in Hematology and 56 papers in Genetics. Recurrent topics in A.R. Bradwell's work include Multiple Myeloma Research and Treatments (45 papers), Monoclonal and Polyclonal Antibodies Research (42 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (42 papers). A.R. Bradwell is often cited by papers focused on Multiple Myeloma Research and Treatments (45 papers), Monoclonal and Polyclonal Antibodies Research (42 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (42 papers). A.R. Bradwell collaborates with scholars based in United Kingdom, United States and France. A.R. Bradwell's co-authors include Robert A. Kyle, Graham P. Mead, Jerry A. Katzmann, Raynell Clark, Hugh D Carr-Smith, Mark T. Drayson, Roshini S. Abraham, James Lymp, Sandra C. Bryant and Colin A. Hutchison and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Oncology.

In The Last Decade

A.R. Bradwell

241 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.

2002 478 citations A.R. Bradwell et al. profile →

Peers

Countries citing papers authored by A.R. Bradwell

Since Specialization

Citations

This map shows the geographic impact of A.R. Bradwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.R. Bradwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.R. Bradwell more than expected).

Fields of papers citing papers by A.R. Bradwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.R. Bradwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.R. Bradwell. The network helps show where A.R. Bradwell may publish in the future.

Co-authorship network of co-authors of A.R. Bradwell

This figure shows the co-authorship network connecting the top 25 collaborators of A.R. Bradwell. A scholar is included among the top collaborators of A.R. Bradwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.R. Bradwell. A.R. Bradwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pulse oximetry for the prediction of acute mountain sickness: A systematic review 2024 ·Experimental Physiology ·(unknown), (unknown), Sophie E. Broughton, (unknown), (unknown), A.R. Bradwell, Samuel J. E. Lucas	3
2	Nocturnal pulse oximetry for the detection and prediction of acute mountain sickness: An observational study 2024 ·Experimental Physiology ·(unknown), (unknown), (unknown), Christopher Bradley, Christopher Lewis, (unknown), Rebekah A. I. Lucas, (unknown), Owen R.T. Thomas, A.R. Bradwell, Samuel J. E. Lucas	4
3	Postexercise urinary alpha-1 acid glycoprotein is not dependent on hypoxia 2021 ·Journal of Applied Physiology ·(unknown), George M. Balanos, Christopher Bradley, (unknown), A.R. Bradwell, Samuel J. E. Lucas	1
4	Effect of losartan on performance and physiological responses to exercise at high altitude (5035 m) 2021 ·BMJ Open Sport & Exercise Medicine ·Samuel J. E. Lucas, (unknown), Owen R.T. Thomas, (unknown), (unknown), (unknown), C. Benjamin Newman, (unknown), Brian Johnson, Steve Myers, Fiona A. Myers, Alexander D. Wright, (unknown), Chris Imray, A.R. Bradwell, Mark Edsell	1
5	Losartan Has No Effect on High Altitude Diuresis or Acute Mountain Sickness in Well-Acclimatizing Individuals 2021 ·High Altitude Medicine & Biology ·(unknown), (unknown), Christopher Lewis, (unknown), A.R. Bradwell	2
6	Hypoxia is not the primary mechanism contributing to exercise-induced proteinuria 2020 ·BMJ Open Sport & Exercise Medicine ·(unknown), (unknown), (unknown), Steve Myers, (unknown), (unknown), Samuel J. E. Lucas, Owen R.T. Thomas, (unknown), Mark Edsell, Fiona A. Myers, (unknown), Chris Imray, (unknown), (unknown), C. Benjamin Newman, Brian Johnson, (unknown), Alexander D. Wright, A.R. Bradwell	3
7	Acetazolamide reduces exercise capacity following a 5-day ascent to 4559 m in a randomised study 2018 ·BMJ Open Sport & Exercise Medicine ·A.R. Bradwell, (unknown), (unknown), (unknown), Owen R.T. Thomas, Samuel J. E. Lucas, Alex Wright, Stephen Harris, Steve Myers	11
8	Urinary Alpha-1-Acid Glycoprotein Is a Sensitive Marker of Glomerular Protein Leakage at Altitude 2018 ·High Altitude Medicine & Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Owen R.T. Thomas, A.R. Bradwell	10
9	Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients 2012 ·Leukemia ·Heinz Ludwig, Dejan Milosavljevic, Niklas Zojer, Jeff Faint, A.R. Bradwell, Wolfgang Hübl, Stephen J. Harding	78
10	1139 ABNORMALLY ELEVATED SERUM FREE LIGHT CHAINS IN PATIENTS WITH LIVER DISEASE 2010 ·Journal of Hepatology ·Lakhvir K. Assi, (unknown), Bridget Gunson, (unknown), Mark T. Drayson, A.R. Bradwell, David Adams	3
11	Serum free light chain and Hevylite analyses in the diagnosis, monitoring and prognosis of B cell disorders 2010 ·Alex Legg, Stephen Harding, (unknown), (unknown), A.R. Bradwell	0
12	Hypercalcaemia of parathyroid carcinoma controlled by immunotherapy 2002 ·Open Repository and Bibliography (University of Liège) ·(unknown), Tim Harvey, Mara Epstein, Albert Beckers, A.R. Bradwell	3
13	RACE-SPECIFIC DR-DQ HAPLOTYPES ALLOW FINER MAPPING OF GENETIC SUSCEPTIBILITY TO TYPE-1 (INSULIN-DEPENDENT) DIABETES 1989 ·Diabetologia ·C. Mijovic, David J.A. Jenkins, J. Fletcher, John A. Todd, A.R. Bradwell, A H Barnett	3
14	EFFECT OF CARBON DIOXIDE IN ACUTE MOUNTAIN SICKNESS: A REDISCOVERY 1988 ·The Lancet ·Tim Harvey, M H Winterborn, Niels A. Lassen, M. E. Raichle, (unknown), N.V. Richardson, A.R. Bradwell	31
15	Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition. 1986 ·BMJ ·C. Mijovic, J. Fletcher, A.R. Bradwell, A H Barnett	19
16	Relation of gene expression (allotypes) of the fourth component of complement to insulin dependent diabetes and its microangiopathic complications. 1985 ·BMJ ·C. Mijovic, J. Fletcher, A.R. Bradwell, Tim Harvey, A H Barnett	22
17	Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes. 1984 ·BMJ ·A H Barnett, C. Mijovic, J. Fletcher, I M Chesner, (unknown), R Holder, A.R. Bradwell	26
18	Improved tumour localisation using indium-111 labelled antibodies. 1983 ·BMJ ·D.S. Fairweather, A.R. Bradwell, (unknown), Andrew Vaughan, (unknown), S. Chandler	82
19	Heberden Society 1981 ·Annals of the Rheumatic Diseases ·Stephen M. Krane, Ann L. Parke, (unknown), P. Gordon, G. R. V. Hughes, (unknown), (unknown), (unknown), Brian E. Henderson, Lucille Bitensky, J. Chayen, John R. Vane, (unknown), David L. Scott, A.R. Bradwell, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
20	Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen. 1980 ·BMJ ·P W Dykes, K R Hine, A.R. Bradwell, (unknown), (unknown), Z Drolc, S. N. Booth	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact